MedPath

University Of Medicine And Dentistry Of New Jersey

University Of Medicine And Dentistry Of New Jersey logo
🇺🇸United States
Ownership
-
Established
1970-01-01
Employees
-
Market Cap
-
Website
http://www.umdnj.edu/

Assessment of the Clinical Utility of Non Invasive Peripheral Signal Averaged Pulse Volume

Completed
Conditions
Peripheral Vascular Response
First Posted Date
2005-09-02
Last Posted Date
2009-08-11
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
16
Registration Number
NCT00143858
Locations
🇺🇸

Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Phase 2
Terminated
Conditions
Cervical Cancer
Interventions
Biological: recombinant interferon alpha-2b
First Posted Date
2005-08-30
Last Posted Date
2013-11-20
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
33
Registration Number
NCT00138151
Locations
🇺🇸

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

🇺🇸

UMDNJ University Hospital, Newark, New Jersey, United States

🇺🇸

Carol G. Simon Cancer Center at Morristown Memorial Hospital, Morristown, New Jersey, United States

and more 3 locations

Study of the Efficacy and Safety of Etanercept in Adults With Vitiligo

Phase 2
Completed
Conditions
Vitiligo
First Posted Date
2005-08-24
Last Posted Date
2008-08-07
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
40
Registration Number
NCT00134368
Locations
🇺🇸

UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, United States

Etanercept With Tacrolimus for Psoriasis

Phase 2
Completed
Conditions
Psoriasis
First Posted Date
2005-08-24
Last Posted Date
2008-08-07
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
20
Registration Number
NCT00134394
Locations
🇺🇸

UMDNJ Psoriasis Center of Excellence, New Brunswick, New Jersey, United States

Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

Phase 3
Completed
Conditions
Borderline Personality Disorder
Interventions
First Posted Date
2005-07-21
Last Posted Date
2008-06-10
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
15
Registration Number
NCT00122070
Locations
🇺🇸

University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine - Department of Psychiatry, Cherry Hill, New Jersey, United States

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Phase 2
Withdrawn
Conditions
Carcinoma of Unknown Primary
First Posted Date
2005-07-13
Last Posted Date
2015-05-27
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Registration Number
NCT00119314
Locations
🇺🇸

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

🇺🇸

Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States

🇺🇸

Hematology and Oncology Group, Somerset, New Jersey, United States

and more 3 locations

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Phase 2
Terminated
Conditions
Lung Cancer
Interventions
First Posted Date
2005-07-11
Last Posted Date
2023-08-15
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
49
Registration Number
NCT00118131
Locations
🇺🇸

UMDNJ - University Hospital, Newark, New Jersey, United States

🇺🇸

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

🇺🇸

JFK Medical Center in Edison, Edison, New Jersey, United States

and more 10 locations

Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
Interventions
Biological: herceptin
Procedure: conventional surgery
Procedure: radiation therapy
First Posted Date
2005-07-11
Last Posted Date
2013-11-20
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Target Recruit Count
5
Registration Number
NCT00118053
Locations
🇺🇸

Saint Peter's University Hospital, New Brunswick, New Jersey, United States

🇺🇸

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

🇺🇸

UMDNJ University Hospital, Newark, New Jersey, United States

and more 6 locations

Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
First Posted Date
2005-01-10
Last Posted Date
2011-06-08
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Registration Number
NCT00101062
Locations
🇺🇸

Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Sulindac and Plant Compounds in Preventing Colon Cancer

Not Applicable
Terminated
Conditions
Colorectal Cancer
First Posted Date
2004-05-21
Last Posted Date
2011-01-27
Lead Sponsor
University of Medicine and Dentistry of New Jersey
Registration Number
NCT00003365
Locations
🇺🇸

Rockefeller University Hospital, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath